Thermo Fisher on Wednesday raised its annual profit outlook and posted a better-than-expected second-quarter profit, banking on improved demand for its tools and services used in clinical
July 24, 2024
U.S. genetic testing company Illumina has been ordered by EU antitrust regulators to sell cancer test maker Grail after it completed the deal before securing their
April 26, 2024
Drugmaker Gilead Sciences on Tuesday said third-quarter sales were little changed from a year earlier, but earnings rose 21% due mainly to lower taxes.
April 26, 2024
Japan's Ajinomoto said on Monday it agreed to acquire U.S.-based genetic medicines maker Forge Biologics Holdings for 82.8 billion yen ($546 million).
April 26, 2024
Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region
January 05, 2024
A congressional committee focused on China has introduced a bill that would restrict federally funded medical providers from allowing China's BGI Group, WuXi Apptec and
April 26, 2024
A draft U.S. bill that has triggered a sell-off in shares of China's biotech firm Wuxi Apptec could deal a major blow not just to the firm but could also impact
April 26, 2024
The U.S. should review Chinese biotech firm WuXi AppTec and its affiliate WuXi Biologics for sanctions, a bipartisan group of lawmakers told top Biden
April 26, 2024
A bill in the U.S.
April 26, 2024
U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi
May 07, 2024
A Republican and a Democratic member of Congress are calling on the Biden administration to add seven Chinese biotech firms to a list created by the Defense Department to
April 26, 2024
Thermo Fisher on Wednesday beat Wall Street estimates for quarterly profit and raised its annual profit forecast, betting on improved demand for its products and services used in drug
May 08, 2024
Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company may provide on its own weight-
May 16, 2024
Illumina reiterated its 2024 revenue forecast on Thursday, expecting continued weak demand from its customers such as medical research labs and hospitals.
May 19, 2024
U.S. legislation that would restrict business with China's BGI, WuXi AppTec and certain other biotech companies on national security grounds was approved by a U.S.
May 30, 2024
The U.S.
June 18, 2024
Swiss drugmaker Roche will team up with privately held biotech Ascidian Therapeutics to develop gene therapies targeting difficult to treat neurological diseases, the Boston-based startup
July 01, 2024
AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi.
June 26, 2024
Alumis is targeting a valuation of up to $1.01 billion in its initial public offering in the United States, the therapy developer said on Monday.
June 24, 2024
Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder of Wegovy maker Novo Nordisk to fund
July 16, 2024
Agilent Technologies said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical
July 22, 2024
Robert Langer, co-founder and a key figure behind Moderna's scientific success, will step down from the vaccine maker's board on Aug. 5, the company said on Tuesday.
July 23, 2024
Indian state minister to meet Samsung officials in bid to resolve strike
European shares jump 1% on tech boost; ECB meet in focus
Zimbabwe blueberry farmers chase booming demand but face funding woes
London's FTSE 100 recovers as US rate cut certainty helps sentiment
Pac-12 targeting Boise St., Fresno St., San Diego St., Colorado St. for rebuild, AP sources say
Murdoch succession battle to play out in Nevada courtroom
Reggie Bush was at his LA-area home when 3 male suspects attempted to break in